Irreversible hearing loss affects hundreds of millions worldwide, often caused by damage to cochlear hair cells that cannot regenerate in humans. New research into the molecular pathways of hair cell ...

The FDA has granted accelerated approval to lunsotogene parvec-cwha (Otarmeni), an adeno-associated virus (AAV) vector–based ...

The kinocilium of vestibular hair cells is a unique organelle with molecular features of primary and motile cilia and may serve as an active, force-generating element within the hair bundle.

The mammalian cochlea is an extraordinary biomechanical system whose capacity for sensitivity and frequency discrimination hinges on intricate interactions between its passive structures and active ...

The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...

The cochlea is the spiral-shaped structure within the inner ear responsible for our sense of hearing. To fully understand hearing functions and open the door to new hearing loss treatments, scientists ...

Research team awarded five-year, $3.2 million grant from National Institute on Deafness and Other Communication Disorders AHL is among the most common health conditions affecting older adults, ...

In the largest and longest trial of its kind, 90% of patients receiving an experimental gene therapy for congenital deafness ...